CELEX: 32021M10486
Language: en
Date: 2021-10-18 00:00:00
Title: Commission Decision of 18/10/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10486 - CDPQ / CENTERBRIDGE / MEDICAL SOLUTIONS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                 Brussels, 18.10.2021
                                                                 C(2021) 7561 final
                                                                                 PUBLIC VERSION
                                                                 Caisse de dépôt et placement du
                                                                 Québec
                                                                 1000 place Jean-Paul-Riopelle
                                                                 H2Z 2B3 Montréal
                                                                 Québec
                                                                 Canada
                                                                 Centerbridge Partners, L.P.
                                                                 375 Park Avenue
                                                                 NY 10152-0002 New York
                                                                 United States of America
Subject:        Case M. 10486 – CDPQ / CENTERBRIDGE / MEDICAL SOLUTIONS
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                (EC) No 139/20041 and Article 57 of the Agreement on the European
                Economic Area2
Dear Sir or Madam,
1.      On 22 September 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which Caisse de
        dépôt et placement du Québec (“CDPQ”, Canada) and Centerbridge Partners, L.P.
        (“Centerbridge”, USA), acquire within the meaning of Article 3(1)(b) and 3(4) of the
        Merger Regulation joint control of Medical Solutions LLC (“Medical Solutions”,
        (United States) by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             for CDPQ: globally active long-term institutional investor managing funds
              primarily for public and para-public pension and insurance plans,
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 398, 1.10.2021, p. 19.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---        for Centerbridge: global investment management firm active across investment
        disciplines from private equity to credit and related strategies, and real estate,
       for Medical Solutions: staffing agency specialising in placing registered nurses,
        allied healthcare professionals, interim clinical leaders, and non-clinical
        professionals.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(a) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                    For the Commission
                                                    (Signed)
                                                    Olivier GUERSENT
                                                    Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                2